Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-country Study on the Prescription Patterns of Short Acting Beta-2 Agonist (SABA) and Its Potential Effects on Asthma Control: A Cross-Sectional Study on SABA Use in Asthma

NCT03857178 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03857178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03857178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-country Study on the Prescription Patterns of Short Acting Beta-2 Agonist (SABA) and Its Potential Effects on Asthma Control: A Cross-Sectional Study on SABA Use in Asthma
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 29, 2019
Completion date
May 6, 2020
Enrollment
8,617 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma